While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced prostate cancers, according to a study in the Journal of the National Cancer Institute (2007; 99:754-64).
Dendreon Corp. said it has received confirmation that the FDA will accept either a positive interim or final analysis of survival from its ongoing IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) study to amend the biologics license application (BLA) for sipuleucel-T (Provenge), a form of immunotherapy in late-stage development for the treatment of hormone-refractory prostate cancer.
The FDA has approved the enzyme inhibitor temsirolimus (Torisel) for the treatment of advanced renal cell carcinoma.
images
Sex is important to men and women worldwide, according to findings from a large global survey, yet a significant proportion of men and women are not completely satisfied with their sex lives.
Results from a recent study that systematically analyzed the data of placebo-controlled trials in patients with BPH confirm that BPH is a progressive disease on the basis of worsening prostate volume, maximum urinary flow, and symptom score, as well as the rate of prostate-related surgery and acute urinary retention.
Value-based purchasing actually has little to do with outcomes in patient care, and has more to do with cost-containment in health care delivery.
The results of a recent study demonstrate that treatment with alpha-blockers has a positive effect on several debilitating symptoms associated with urination in patients receiving double-J stents.
The federal government is pressing forward with an initiative launched by the Medicare Modernization Act of 2003 (MMA) to implement a national system of electronic prescriptions intended to increase both efficiency and patient safety.
A new continuous wave thulium laser device appears to offer a safe, bloodless, effective, and expeditious outpatient surgical procedure for men with BPH.
Interest in international real estate is increasing because, as is often the case with investors, it recently has done very well from a performance standpoint.
Most urologists have patients who come from many different backgrounds, speak different languages, and have different attitudes toward Western medicine.
The Physician Quality Reporting Initiative (PQRI) is a program established at the end of last year to provide incentive funding for physicians to begin submitting data that will be used to make Medicare a smarter purchaser of health care.
This article centers around the rationale and outcomes of the converse issue; namely, removal of metastatic extrarenal foci of RCC.
Research has shown that penile hemodynamic findings are related to vascular risk factors.
Obesity is definitively associated with both metabolic alterations and urinary stone recurrence.
Results of an Italian study comparing transobturator suburethral tape (TOT) and tension-free vaginal tape (TVT) show both surgical techniques to be equally efficient at a follow-up of nearly 3 years in women suffering from stress urinary incontinence.
Results from a recent study that systematically analyzed the data of placebo-controlled trials in patients with BPH confirm that BPH is a progressive disease on the basis of worsening prostate volume, maximum urinary flow, and symptom score, as well as the rate of prostate-related surgery and acute urinary retention.
Many physicians are concerned and confused about all the discussion on pay for performance, and urologists are no exception.
Preliminary results from the REDUCE (REduction by DUtasteride of prostate Cancer Events) trial suggest a relationship between the degree of chronic inflammation and lower urinary tract symptoms, but not clinical prostatitis-like symptoms in the REDUCE population.
After nearly 7 years of follow-up, cryoablation appears to be as effective as external beam radiation therapy (EBRT) in the treatment of localized prostate cancer, according to the results of a prospective, randomized trial.
About 110 urologists met in the nation's capitol in March to learn more about the important public policy and payment issues shaping practices across the country.
Data from two similarly designed European studies comparing photoselective vaporization of the prostate and transurethral resection of the prostate show similar outcomes after a 2-year follow-up in patients with lower urinary tract symptoms due to BPH.
A laparoscopic preperitoneal approach cannot only serve as a teaching platform for laparoscopic skills for surgeons, but it also demonstrates reproducible outcomes in the treatment of BPH.
Urologist Andrew von Eschenbach, MD, was named commissioner of the Food and Drug Administration in 2006. In this exclusive interview, from Urology Times sister publication Pharmaceutical Executive, he discusses drug safety, DTC advertising, FDA's culture, and how the agency plans to bring itself into the age of molecular medicine.
New urology products and services.
Men who present with infertility issues and their partners are relatively uninformed about the causes and treatments of male infertility, a fact that may be attributable to urologists' failure to properly market their capabilities in this area of clinical practice, says a University of Connecticut, Farmington, urologist.
Listen to the Urology Times Radio podcast from Day Five of the 2007 AUA Annual Meeting in Anaheim, California. This podcast includes interviews with highly regarded experts in urological medicine including: Daniel Kaplon, MD, reports on the risk of osteopenia in infertile men Stanton Honig, MD, discusses patients' understanding of male infertilityPeter Chan, MD, explains why routine semen analysis fails to predict reproductive outcomes
The AUA Foundation has named the 2007 class for its Research Scholars Program.
Men who present with infertility issues and their partners are relatively uninformed about the causes and treatments of male infertility, a fact that may be attributable to urologists' failure to properly market their capabilities in this area of clinical practice, says a University of Connecticut, Farmington, urologist.
